English | Español
Ruth de Jauregui | Jun 7, 2017

Study indicates positive results using smaller, combination doses of blood pressure medication
Ruth de Jauregui | Jun 7, 2017

Bristol-Myers Squibb, Novartis to study combination treatment for colorectal cancer
Ruth de Jauregui | Jun 7, 2017

AstraZeneca sees positive results in treating BRCA-mutated breast cancer patients with Lynparza
Erianne Leatherman | Jun 6, 2017

Novartis highlighting cancer care data at national, international forums
Erianne Leatherman | Jun 6, 2017

Zykadia under consideration in Europe for expanded use to treat non-small cell lung cancer
Ruth de Jauregui | Jun 4, 2017

Advaxis, Bristol-Myers Squibb to collaborate in metastatic cervical cancer study
Erianne Leatherman | Jun 4, 2017

Revision to heart failure guideline released
Ruth de Jauregui | Jun 4, 2017

National Institute of Health announces promising influenza study tool

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’